Graph neural networks for the identification of novel inhibitors of a small RNA

High Expression Levels of miR-21-5p in Younger Hospitalized COVID-19 Patients Are Associated with Mortality and Critical Disease

(2023) Brandon Bautista-Becerril et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Delivery of anti-microRNA-21 by lung-targeted liposomes for pulmonary fibrosis treatment

(2023) Lingyue Yan et al.   Molecular Therapy-Nucleic Acids

Strategies for targeting RNA with small molecule drugs

(2022) Christopher L. Haga et al.   Expert Opinion on Drug Discovery

Predicting Protein–Ligand Docking Structure with Graph Neural Network

(2022) Huaipan Jiang et al.   Journal of Chemical Information and Modeling

Graph neural networks for automated de novo drug design

(2021) Jiacheng Xiong et al.   DRUG DISCOVERY TODAY

Generative Models for De Novo Drug Design

(2021) Xiaochu Tong et al.   JOURNAL OF MEDICINAL CHEMISTRY

Molecular Docking: Shifting Paradigms in Drug Discovery

(2019) Luca Pinzi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Graph Convolutional Neural Networks for Predicting Drug-Target Interactions

(2019) Wen Torng et al.   Journal of Chemical Information and Modeling

Statistical and machine learning approaches to predicting protein–ligand interactions

(2018) Lucy J Colwell   CURRENT OPINION IN STRUCTURAL BIOLOGY

Baicalein represses TGF-β1-induced fibroblast differentiation through the inhibition of miR-21

(2018) Xinjian Cui et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Small Molecule Inhibition of miR-544 Biogenesis Disrupts Adaptive Responses to Hypoxia by Modulating ATM-mTOR Signaling

(2015) Christopher L. Haga et al.   ACS Chemical Biology

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

(2014) Luca Richeldi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Baicalein attenuates bleomycin-induced pulmonary fibrosis in rats through inhibition of miR-21

(2013) Yan Gao et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

(2011) Paul W Noble et al.   LANCET

MicroRNAs in idiopathic pulmonary fibrosis

(2011) Kusum V. Pandit et al.   Translational Research

miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis

(2010) Gang Liu et al.   JOURNAL OF EXPERIMENTAL MEDICINE